Skip to content

INNOVUS PHARMACEUTICALS, INC.: filings

Every INNOVUS PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 35 filings, each linked to its SEC index.

Filing record ends 2019-11-14

The latest filing in this captured record is a 10-Q filed 2019-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. INNOVUS PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-11-14fiscal Q3 2019391060001437749-19-022728
10-Q2019-08-13fiscal Q2 2019401030001437749-19-016550
10-Q2019-05-15fiscal Q1 201939760001437749-19-010044
10-K2019-04-01fiscal FY 201843840001437749-19-006219
10-Q2018-11-14fiscal Q3 201837900001437749-18-020819
10-Q2018-08-14fiscal Q2 201833840001654954-18-009098
10-Q2018-05-14fiscal Q1 201832620001654954-18-005226
10-K2018-04-02fiscal FY 201741820001654954-18-003500
10-Q2017-11-14fiscal Q3 201735920001654954-17-010623
10-Q2017-08-14fiscal Q2 201734910001654954-17-007532
10-Q2017-05-15fiscal Q1 201733640001654954-17-004629
10-K2017-03-09fiscal FY 201640800001654954-17-001819
10-Q2016-11-14fiscal Q3 201632790001654954-16-004030
10-Q2016-08-15fiscal Q2 201632810001415889-16-006852
10-Q2016-05-16fiscal Q1 201631610001415889-16-005940
10-K2016-03-30fiscal FY 201538750001415889-16-005397
10-Q2015-11-16fiscal Q3 201533730001415889-15-003754
10-Q2015-08-14fiscal Q2 201533730001415889-15-002725
10-Q2015-05-15fiscal Q1 201531560001415889-15-001753
10-K2015-03-31fiscal FY 201432590001415889-15-001153
10-Q2014-11-14fiscal Q3 201431650001415889-14-003490
10-Q2014-08-14fiscal Q2 201430650001415889-14-002518
10-Q2014-05-14fiscal Q1 201428520001144204-14-030375
10-K2014-03-28fiscal FY 201330780001144204-14-018763
10-Q2013-11-14fiscal Q3 201322690001144204-13-061934
10-Q2013-08-13fiscal Q2 201321700001144204-13-045181
10-Q2013-05-10fiscal Q1 201319600001144204-13-028024
10-K/A2013-03-27fiscal FY 201220600001144204-13-017983
10-Q2012-10-24fiscal Q3 201219680001144204-12-057485
10-Q/A2012-10-05fiscal Q2 201217580001144204-12-054919
10-Q/A2012-09-05fiscal Q2 201217580001144204-12-049695
10-Q2012-05-10fiscal Q1 201216410001144204-12-027544
10-K2012-03-30fiscal FY 201117460001144204-12-018381
10-Q2011-10-19fiscal Q3 201113400001411879-11-000040
10-Q/A2011-08-31fiscal Q2 201113420001411879-11-000027

Inspect the source

Entity
INNOVUS PHARMACEUTICALS, INC. / CIK 0001411879
Captured
SEC response SHA-256
e77a101a672b8634c33f41442578c32e719835a043b28e20b379158f9e2f8bab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))